Correlation Between Hemogenyx Pharmaceuticals and Baker Hughes

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hemogenyx Pharmaceuticals and Baker Hughes at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hemogenyx Pharmaceuticals and Baker Hughes into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hemogenyx Pharmaceuticals PLC and Baker Hughes Co, you can compare the effects of market volatilities on Hemogenyx Pharmaceuticals and Baker Hughes and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hemogenyx Pharmaceuticals with a short position of Baker Hughes. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hemogenyx Pharmaceuticals and Baker Hughes.

Diversification Opportunities for Hemogenyx Pharmaceuticals and Baker Hughes

-0.3
  Correlation Coefficient

Very good diversification

The 3 months correlation between Hemogenyx and Baker is -0.3. Overlapping area represents the amount of risk that can be diversified away by holding Hemogenyx Pharmaceuticals PLC and Baker Hughes Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Baker Hughes and Hemogenyx Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hemogenyx Pharmaceuticals PLC are associated (or correlated) with Baker Hughes. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Baker Hughes has no effect on the direction of Hemogenyx Pharmaceuticals i.e., Hemogenyx Pharmaceuticals and Baker Hughes go up and down completely randomly.

Pair Corralation between Hemogenyx Pharmaceuticals and Baker Hughes

Assuming the 90 days trading horizon Hemogenyx Pharmaceuticals PLC is expected to generate 37.08 times more return on investment than Baker Hughes. However, Hemogenyx Pharmaceuticals is 37.08 times more volatile than Baker Hughes Co. It trades about 0.05 of its potential returns per unit of risk. Baker Hughes Co is currently generating about 0.09 per unit of risk. If you would invest  88,000  in Hemogenyx Pharmaceuticals PLC on October 10, 2024 and sell it today you would lose (49,250) from holding Hemogenyx Pharmaceuticals PLC or give up 55.97% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy99.6%
ValuesDaily Returns

Hemogenyx Pharmaceuticals PLC  vs.  Baker Hughes Co

 Performance 
       Timeline  
Hemogenyx Pharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hemogenyx Pharmaceuticals PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.
Baker Hughes 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Baker Hughes Co are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Baker Hughes unveiled solid returns over the last few months and may actually be approaching a breakup point.

Hemogenyx Pharmaceuticals and Baker Hughes Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hemogenyx Pharmaceuticals and Baker Hughes

The main advantage of trading using opposite Hemogenyx Pharmaceuticals and Baker Hughes positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hemogenyx Pharmaceuticals position performs unexpectedly, Baker Hughes can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Baker Hughes will offset losses from the drop in Baker Hughes' long position.
The idea behind Hemogenyx Pharmaceuticals PLC and Baker Hughes Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.

Other Complementary Tools

Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio